Cytotoxicity of dihydroartemisinin toward Molt-4 cells attenuated by N-tert-butyl-alpha-phenylnitrone and deferoxamine

Anticancer Research

Volumn 33, Issue 10, 2013, Pages 4389-4394

  Chan, Ho Wing ^a   Singh, Narendra P ^a   Lai, Henry C ^a  

^a University of Washington   (United States)

Author keywords

Deferoxamine; Dihydroartemisinin; Free radical; Iron; Molt 4 cells; N tert butyl alpha phenylnitrone

Indexed keywords

DEFEROXAMINE; DIHYDROARTEMISININ; N TERT BUTYL ALPHA PHENYLNITRONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL COUNT; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL;

DEFEROXAMINE; DIHYDROARTEMISININ; FREE RADICAL; IRON; MOLT-4 CELLS; N-TERT-BUTYL-ALPHA-PHENYLNITRONE;

ANTINEOPLASTIC AGENTS; ARTEMISININS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC N-OXIDES; DEFEROXAMINE; DRUG ANTAGONISM; DRUG SCREENING ASSAYS, ANTITUMOR; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; SIDEROPHORES;

EID: 84891353549     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lai H, Singh NP and Sasaki T: Development of artemisinin compounds for cancer treatment. Invest New Drugs 31: 230-246, 2013.
2. Lai H and Singh NP: Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin. Cancer Lett 91: 41-46, 1995.
3. Singh NP and Lai H: Selective toxicity of dehydroartemisinin and holotransferrin on human breast cancer cells. Life Sci 70: 49-56, 2001.
4. Karin M and Mintz B: Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells. J Bio Chem 256: 3245-3252, 1981.
5. May WS and Cuatrecasas P: Transferrin receptor: its biological significance. J Membr Biol 88 : 205-215, 1985.
6. Reinke LA, Lai EK, DuBose CM and McCay PB: Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci USA 84: 9223-9227, 1987.
7. Sen S and Phillis JW: Alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study. Free Radic Res Commun 19: 255-265, 1993.
8. Lu JJ, Meng LH, Cai YJ, Chen Q, Tong LJ, Lin LP and Ding J: Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species. Cancer Biol Ther 7: 1017-1023, 2008.
9. Singh NP and Lai H: Artemisinin induces apoptosis in human cancer cells. Anticancer Res 24 : 2277-2280, 2004.
10. Lai H, Nakase I, Lacoste E, Singh NP and Sasaki T: Artemisinin- transferrin conjugate retards growth of breast tumors in the rat. Anticancer Res 29: 3807-3810, 2009.
11. Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC and Arnaud P: Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull 25 : 1600-1603, 2002.
12. Singh NP and Lai HC: Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells. Anticancer Res 25: 4325-4331, 2005.
13. Krauth J: Nonparametric analysis of response curves. J Neurosci Method 2: 239-252, 1980.
14. Lu JJ, Chen SM, Zhang XW, Ding J and Meng LH: The anticancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. Invest New Drugs 29: 1276-1283, 2011.
15. Berdelle N, NikolovaT, Quiros S, Efferth T and Kaina B: Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol Cancer Ther 10 : 2224-2233, 2011.
16. Floyd RA, Towner RA, Wu D, Abbott A, Cranford R, Branch D, Guo WX, Foster SB, Jones I, Alam R, Moore D, Allen T and Huycke M: Anticancer activity of nitrones in the Apc(Min/+) model of colorectal cancer. Free Radic Res 44 : 108-117, 2010.
17. Kaplinsky C, Estrov Z, Freedman MH, Gelfand EW and Cohen A: Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells. Leukemia 1: 437-441, 1987.
18. Zhang S, Chen H and Gerhard GS: Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers. Chem Biol Interact 186: 30-35, 2010.
19. Sun WC, Han JX, Yang WY, Deng DA and Yue XF: Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro. Zhongguo Yao Li Xue Bao 13 : 541-543, 1992. [article in Chinese].
20. Lu JJ, Meng LH, Shankavaram UT, Zhu CH, Tong LJ, Chen G, Lin LP, Weinstein JN and Ding J: Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Biochem Pharmacol 80 : 22-30, 2010.
21. Lu JJ, Yang Z, Lu DZ, Wo XD, Shi JJ, Lin TQ, Wang MM, Li Y and Tang LH: Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: An analysis of the mitochondrial proteome. Mol Med Rep 6 : 429-433, 2012.
22. Zhou HJ, Wang Z and Li A: Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via down-regulation of transferrin receptor expression. Anticancer Drugs 19: 247-255, 2008.